BiotechTube
Home/Okogen/David A. Hollander, MD, MBA
DA

David A. Hollander, MD, MBA

Chief Medical Officer

Okogen

Therapeutic Areas

OphthalmologyInfectious Disease

Okogen Pipeline

DrugIndicationPhase
OKG-0303Acute Infectious Conjunctivitis (Bacterial and Viral)Phase 2b

Leadership Team at Okogen

JH
Joshua H. Moriarty
Chief Executive Officer & Director
BA
Bradford A. Conlan
Executive Chairman
BM
Brian M Strem, PhD
Non-Executive Director, Co-founder
View full Okogen profile